HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Hiramine Selected Research

HCV NS3-4A Protease Inhibitors

9/2014A case of successful treatment with telaprevir-based triple therapy for hepatitis C infection after treatment failure with vaniprevir-based triple therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Hiramine Research Topics

Disease

4Hepatitis C
12/2021 - 09/2014
4Infections
01/2017 - 12/2012
4HIV Infections (HIV Infection)
01/2017 - 01/2014
2Immune Reconstitution Inflammatory Syndrome
01/2017 - 04/2015
2Chronic Hepatitis C
01/2014 - 12/2012
1COVID-19
08/2022
1Thrombosis (Thrombus)
08/2022
1Thrombocytopenia (Thrombopenia)
08/2022
1Respiratory Insufficiency (Respiratory Failure)
08/2022
1Pulmonary Embolism
08/2022
1Glucose Intolerance
12/2021
1Atherosclerosis
12/2021
1Non-alcoholic Fatty Liver Disease
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Fatty Liver
01/2020
1Virus Diseases (Viral Diseases)
01/2017
1Inflammation (Inflammations)
01/2017
1Bacterial Infections (Bacterial Infection)
01/2017
1Prediabetic State (Prediabetes)
06/2016
1Persistent Infection
03/2016
1Diabetes Mellitus
06/2015
1Hepatitis B
04/2015
1Carotid Artery Diseases
02/2015
1Chronic Renal Insufficiency
02/2015
1Anemia
09/2014
1Liver Diseases (Liver Disease)
05/2014
1Coinfection
05/2014
1Hemophilia A (Haemophilia)
05/2014

Drug/Important Bio-Agent (IBA)

4AlbuminsIBA
12/2021 - 06/2015
3telaprevirIBA
11/2015 - 05/2014
3Ribavirin (Virazole)FDA LinkGeneric
09/2014 - 01/2014
3InterferonsIBA
09/2014 - 01/2014
3Antiviral Agents (Antivirals)IBA
09/2014 - 12/2012
2Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
06/2016 - 06/2015
1Heparin (Liquaemin)FDA LinkGeneric
08/2022
1fibrin fragment D (D-dimer)IBA
08/2022
1apixabanIBA
08/2022
1remdesivirIBA
08/2022
1AnticoagulantsIBA
08/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2022
1Inositol (Myoinositol)IBA
12/2021
1InterleukinsIBA
12/2021
1HDL CholesterolIBA
12/2021
1LDL CholesterolIBA
12/2021
1Phospholipases (Phospholipase)IBA
01/2020
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020
1C-Reactive ProteinIBA
01/2017
1IgG Receptors (Fc gamma RI)IBA
01/2017
1EndostatinsIBA
06/2016
1RNA (Ribonucleic Acid)IBA
03/2016
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2015
1Hepatitis B e AntigensIBA
04/2015
1Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2015
1AntigensIBA
04/2015
1Triglycerides (Triacylglycerol)IBA
02/2015
1HCV NS3-4A Protease InhibitorsIBA
09/2014
1vaniprevirIBA
09/2014
1Pharmaceutical PreparationsIBA
09/2014
1Emtricitabine (Emtriva)FDA Link
05/2014
1Tenofovir (Viread)FDA Link
05/2014
1Protease Inhibitors (Protease Inhibitor)IBA
05/2014
1Blood Coagulation Factors (Coagulation Factor)IBA
05/2014
1Raltegravir PotassiumFDA Link
05/2014
1Raloxifene Hydrochloride (Evista)FDA Link
12/2012

Therapy/Procedure

5Therapeutics
08/2022 - 01/2014
4Art Therapy
01/2017 - 01/2014
2Aftercare (After-Treatment)
08/2022 - 09/2014